• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分裂增强子-1(HES-1)是Notch1效应蛋白,可抑制类癌肿瘤细胞的生长。

Hairy Enhancer of Split-1 (HES-1), a Notch1 effector, inhibits the growth of carcinoid tumor cells.

作者信息

Kunnimalaiyaan Muthusamy, Yan Sonia, Wong Francis, Zhang Yi-Wei, Chen Herbert

机构信息

Department of Surgery, The University of Wisconsin Medical School, University of Wisconsin Comprehensive Cancer Center, Madison, WI, USA.

出版信息

Surgery. 2005 Dec;138(6):1137-42; discussion 1142. doi: 10.1016/j.surg.2005.05.027.

DOI:10.1016/j.surg.2005.05.027
PMID:16360401
Abstract

BACKGROUND

The Notch1-signaling pathway has been shown to regulate the differentiation and growth of carcinoid tumor cells. However, the molecules that mediate Notch1 signaling, as well as their potential roles in regulating the growth of carcinoid tumors, have not been characterized. We and others have shown previously that the transcription factor Hairy Enhancer of Split-1 (HES-1) is upregulated in response to Notch1 signaling, demonstrating that it is a Notch1 effector. We hypothesized that HES-1 may be the essential downstream factor in Notch1-mediated growth regulation of carcinoid tumors.

METHODS

H727 carcinoid tumor cells were transduced stably with a doxycycline-inducible HES-1 construct, creating H727-HES-1 cells. H727-TRE (vector-only control) and H727-HES-1 cells were then treated with varying concentrations of doxycycline to achieve increasing levels of HES-1 protein expression. Cell proliferation was determined with the use of a cell viability assay.

RESULTS

Treatment of H727-HES-1 cells with increasing dosages of doxycycline resulted in dose-dependent increases in HES-1 protein by Western blot analysis. Importantly, induction of HES-1 in carcinoid tumor cells led to suppression of tumor cellular proliferation. Moreover, the degree of carcinoid growth inhibition appeared to be proportional to the level of HES-1 induction.

CONCLUSIONS

HES-1 alone can regulate the growth of carcinoid tumor cells. Furthermore, these results suggest that HES-1 may be the critical downstream effector in the Notch1-signaling pathway.

摘要

背景

Notch1信号通路已被证明可调节类癌肿瘤细胞的分化和生长。然而,介导Notch1信号传导的分子及其在调节类癌肿瘤生长中的潜在作用尚未明确。我们和其他人之前已经表明,转录因子分裂增强子-1(HES-1)在Notch1信号传导的反应中上调,表明它是一种Notch1效应物。我们假设HES-1可能是Notch1介导的类癌肿瘤生长调节中的关键下游因子。

方法

用强力霉素诱导的HES-1构建体稳定转导H727类癌肿瘤细胞,产生H727-HES-1细胞。然后用不同浓度的强力霉素处理H727-TRE(仅载体对照)和H727-HES-1细胞,以实现HES-1蛋白表达水平的增加。使用细胞活力测定法测定细胞增殖。

结果

通过蛋白质印迹分析,用增加剂量的强力霉素处理H727-HES-1细胞导致HES-1蛋白呈剂量依赖性增加。重要的是,类癌肿瘤细胞中HES-1的诱导导致肿瘤细胞增殖的抑制。此外,类癌生长抑制程度似乎与HES-1诱导水平成比例。

结论

单独的HES-1可以调节类癌肿瘤细胞的生长。此外,这些结果表明HES-1可能是Notch1信号通路中的关键下游效应物。

相似文献

1
Hairy Enhancer of Split-1 (HES-1), a Notch1 effector, inhibits the growth of carcinoid tumor cells.分裂增强子-1(HES-1)是Notch1效应蛋白,可抑制类癌肿瘤细胞的生长。
Surgery. 2005 Dec;138(6):1137-42; discussion 1142. doi: 10.1016/j.surg.2005.05.027.
2
Conservation of the Notch1 signaling pathway in gastrointestinal carcinoid cells.Notch1信号通路在胃肠道类癌细胞中的保守性。
Am J Physiol Gastrointest Liver Physiol. 2005 Oct;289(4):G636-42. doi: 10.1152/ajpgi.00146.2005.
3
Curcumin-mediated regulation of Notch1/hairy and enhancer of split-1/survivin: molecular targeting in cholangiocarcinoma.姜黄素介导的Notch1/毛状分裂增强子1/生存素调控:胆管癌中的分子靶向作用
J Surg Res. 2015 Oct;198(2):434-40. doi: 10.1016/j.jss.2015.03.029. Epub 2015 Mar 19.
4
Prognostic significance of Hes-1, a downstream target of notch signaling in hepatocellular carcinoma.Hes-1在肝细胞癌中作为Notch信号通路的下游靶点的预后意义。
Asian Pac J Cancer Prev. 2015;16(9):3811-6. doi: 10.7314/apjcp.2015.16.9.3811.
5
Regulation of neuroendocrine differentiation in gastrointestinal carcinoid tumor cells by notch signaling.Notch信号通路对胃肠道类癌肿瘤细胞神经内分泌分化的调控
J Clin Endocrinol Metab. 2005 Jul;90(7):4350-6. doi: 10.1210/jc.2005-0540. Epub 2005 May 3.
6
Chrysin activates Notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma in vitro and in vivo.白杨素激活 Notch1 信号通路并在体内外抑制间变性甲状腺癌的生长。
Cancer. 2013 Feb 15;119(4):774-81. doi: 10.1002/cncr.27742. Epub 2012 Sep 18.
7
Hesperetin activates the Notch1 signaling cascade, causes apoptosis, and induces cellular differentiation in anaplastic thyroid cancer.橙皮素激活Notch1信号级联反应,导致细胞凋亡,并诱导间变性甲状腺癌的细胞分化。
Ann Surg Oncol. 2014 Dec;21 Suppl 4(0 4):S497-504. doi: 10.1245/s10434-013-3459-7. Epub 2014 Jan 14.
8
Interference of Notch1 inhibits the growth of glioma cancer cells by inducing cell autophagy and down-regulation of Notch1-Hes-1 signaling pathway.Notch1的干扰通过诱导细胞自噬和下调Notch1-Hes-1信号通路来抑制胶质瘤癌细胞的生长。
Med Oncol. 2015 Jun;32(6):610. doi: 10.1007/s12032-015-0610-2. Epub 2015 Apr 29.
9
Xanthohumol-Mediated Suppression of Notch1 Signaling Is Associated with Antitumor Activity in Human Pancreatic Cancer Cells.黄腐酚介导的Notch1信号通路抑制与人类胰腺癌细胞的抗肿瘤活性相关。
Mol Cancer Ther. 2015 Jun;14(6):1395-403. doi: 10.1158/1535-7163.MCT-14-0915. Epub 2015 Apr 17.
10
Insulinoma-Associated Protein 1 Is a Crucial Regulator of Neuroendocrine Differentiation in Lung Cancer.胰岛素瘤相关蛋白1是肺癌神经内分泌分化的关键调节因子。
Am J Pathol. 2015 Dec;185(12):3164-77. doi: 10.1016/j.ajpath.2015.08.018. Epub 2015 Oct 23.

引用本文的文献

1
Diagnostic and Predictive Role of DLL3 Expression in Gastroenteropancreatic Neuroendocrine Neoplasms.DLL3 表达在胃肠胰神经内分泌肿瘤中的诊断和预测作用。
Endocr Pathol. 2021 Jun;32(2):309-317. doi: 10.1007/s12022-020-09657-8. Epub 2021 Jan 6.
2
Heterogeneity of Vascular Endothelial Cells, De Novo Arteriogenesis and Therapeutic Implications in Pancreatic Neuroendocrine Tumors.胰腺神经内分泌肿瘤中血管内皮细胞的异质性、新生血管生成及其治疗意义
J Clin Med. 2019 Nov 14;8(11):1980. doi: 10.3390/jcm8111980.
3
Orthopedia Homeobox (OTP) in Pulmonary Neuroendocrine Tumors: The Diagnostic Value and Possible Molecular Interactions.
肺神经内分泌肿瘤中的正位同源框(OTP):诊断价值及可能的分子相互作用
Cancers (Basel). 2019 Oct 8;11(10):1508. doi: 10.3390/cancers11101508.
4
Updates on the Role of Molecular Alterations and NOTCH Signalling in the Development of Neuroendocrine Neoplasms.神经内分泌肿瘤发生发展中分子改变及NOTCH信号传导作用的研究进展
J Clin Med. 2019 Aug 22;8(9):1277. doi: 10.3390/jcm8091277.
5
Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targets.胃肠胰神经内分泌肿瘤的靶向治疗:临床前策略与未来靶点
Endocr Connect. 2018 Jan;7(1):R1-R25. doi: 10.1530/EC-17-0286. Epub 2017 Nov 16.
6
Notch as a tumour suppressor.Notch 作为一种肿瘤抑制因子。
Nat Rev Cancer. 2017 Mar;17(3):145-159. doi: 10.1038/nrc.2016.145. Epub 2017 Feb 3.
7
The Phosphatidylinositol 3-kinase/Akt Signaling Pathway in Neuroendocrine Tumors.神经内分泌肿瘤中的磷脂酰肌醇3-激酶/蛋白激酶B信号通路
Glob J Biochem. 2012;3. Epub 2011 Mar 8.
8
Goblet cell carcinoids of the appendix: Tumor biology, mutations and management strategies.阑尾杯状细胞类癌:肿瘤生物学、突变与管理策略
World J Gastrointest Surg. 2016 Oct 27;8(10):660-669. doi: 10.4240/wjgs.v8.i10.660.
9
A Phase II Trial of a Histone Deacetylase Inhibitor Panobinostat in Patients With Low-Grade Neuroendocrine Tumors.一项关于组蛋白去乙酰化酶抑制剂帕比司他治疗低级别神经内分泌肿瘤患者的II期试验。
Oncologist. 2016 Jul;21(7):785-6. doi: 10.1634/theoncologist.2016-0060. Epub 2016 Jun 3.
10
Notch Signaling in Neuroendocrine Tumors.神经内分泌肿瘤中的Notch信号通路
Front Oncol. 2016 Apr 14;6:94. doi: 10.3389/fonc.2016.00094. eCollection 2016.